Committed to responsible pain management
Developing innovative and differentiated products for people suffering from pain
At Collegium Pharmaceutical we are committed to being the leader in responsible pain management. We have developed a portfolio of meaningfully differentiated products for use in the treatment of moderate to severe pain.
News and Press
Collegium Reports Record Full-Year 2020 Revenue of $310.0 MillionRead More February 25, 2021
Collegium to Host Conference Call to Discuss Fourth Quarter 2020 Financial Results and Provide Corporate UpdateRead More February 11, 2021